Mirko Bibl

Highly conserved and disease‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer's disease and in patients with chronic neuroinflammation

Jens Wiltfang, Hermann Esselmann, Mirko Bibl et al. · Journal of Neurochemistry · 2002 · 271 citations · Full text

Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho‐Tau in patients with low‐ and high‐CSF Aβ40 load

Jens Wiltfang, Hermann Esselmann, Mirko Bibl et al. · Journal of Neurochemistry · 2006 · 253 citations · Full text

Amyloid β, Neurochemical Biomarkers, Alzheimer's Disease +20

CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

Mirko Bibl, Brit Mollenhauer, Hermann Esselmann et al. · Brain · 2006 · 206 citations · Full text

Neurochemical Biomarkers, Social Sciences, Abeta Peptide Pattern +20

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study

Piotr Lewczuk, Heike Kamrowski‐Kruck, Oliver Peters et al. · Molecular Psychiatry · 2008 · 160 citations

Neuroimaging Biomarkers, Alzheimer's Disease, Medicine +9

Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease

Volker Welge, Oliver Fiege, Piotr Lewczuk et al. · Journal of Neural Transmission · 2009 · 144 citations · Full text

Neurodegenerative Diseases, Csf Tau, Alzheimer's Disease +12